Skip to content

Drug interactions

Fosaprepitant + Montelukast

Severity: Minor

Fosaprepitant and Montelukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor after single doses, so montelukast levels could rise slightly. Given the single or short-course use and montelukast's safety margin, the effect is unlikely to matter.

What this interaction means in plain words

Fosaprepitant and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fosaprepitant belongs to Gastrointestinal Tract; Montelukast belongs to Respiratory.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4, modestly reducing montelukast metabolism.

What to do

No dose adjustment is required. Monitor for adverse effects if used repeatedly.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosaprepitant and Montelukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosaprepitant with Montelukast?

MediHelp rates the interaction as minor. Fosaprepitant and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor after single doses, so montelukast levels could rise slightly. Given the single or short-course use and montelukast's safety margin, the effect is unlikely to matter.

How serious is the interaction between Fosaprepitant and Montelukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is required. Monitor for adverse effects if used repeatedly.

What other medicines interact with Montelukast?

MediHelp also lists interactions of Montelukast with, for example, Apalutamide, Carbamazepine, Deferasirox. The full list is on the Montelukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in